SignatureFD’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.67K | Sell |
49
-112
| -70% | -$7.2K | ﹤0.01% | 2967 |
|
|
2026
Q1 | $9.07K | Buy |
161
+2
| +1% | +$130 | ﹤0.01% | 2561 |
|
|
2025
Q4 | $12.7K | Buy |
159
+91
| +134% | +$6.11K | ﹤0.01% | 2316 |
|
|
2025
Q3 | $3.31K | Sell |
68
-119
| -64% | -$7.37K | ﹤0.01% | 2797 |
|
|
2025
Q2 | $14K | Sell |
187
-19
| -9% | -$1.26K | ﹤0.01% | 2208 |
|
|
2025
Q1 | $13.1K | Hold |
206
| – | – | ﹤0.01% | 2259 |
|
|
2024
Q4 | $16.1K | Sell |
206
-20
| -9% | -$1.61K | ﹤0.01% | 2170 |
|
|
2024
Q3 | $18.2K | Sell |
226
-76
| -25% | -$6.14K | ﹤0.01% | 2087 |
|
|
2024
Q2 | $25K | Sell |
302
-19
| -6% | -$1.67K | ﹤0.01% | 1851 |
|
|
2024
Q1 | $27.4K | Sell |
321
-128
| -29% | -$10K | ﹤0.01% | 1841 |
|
|
2023
Q4 | $38.4K | Hold |
449
| – | – | ﹤0.01% | 1597 |
|
|
2023
Q3 | $40.2K | Hold |
449
| – | – | ﹤0.01% | 1500 |
|
|
2023
Q2 | $38.2K | Hold |
449
| – | – | ﹤0.01% | 1570 |
|
|
2023
Q1 | $37.2K | Buy |
449
+137
| +44% | +$11.1K | ﹤0.01% | 1527 |
|
|
2022
Q4 | $24.5K | Hold |
312
| – | – | ﹤0.01% | 1708 |
|
|
2022
Q3 | $23K | Buy |
312
+46
| +17% | +$3.3K | ﹤0.01% | 1671 |
|
|
2022
Q2 | $17K | Buy |
266
+173
| +186% | +$10.2K | ﹤0.01% | 1857 |
|
|
2022
Q1 | $6K | Buy |
93
+32
| +52% | +$1.74K | ﹤0.01% | 2398 |
|
|
2021
Q4 | $3K | Sell |
61
-233
| -79% | -$14.2K | ﹤0.01% | 2583 |
|
|
2021
Q3 | $21K | Buy |
294
+218
| +287% | +$13.8K | ﹤0.01% | 1735 |
|
|
2021
Q2 | $5K | Buy |
76
+59
| +347% | +$4.17K | ﹤0.01% | 2271 |
|
|
2021
Q1 | $2K | Sell |
17
-9
| -35% | -$1.11K | ﹤0.01% | 2475 |
|
|
2020
Q4 | $3K | Buy |
26
+14
| +117% | +$1.51K | ﹤0.01% | 2127 |
|
|
2020
Q3 | $1K | Sell |
12
-7
| -37% | -$612 | ﹤0.01% | 2420 |
|
|
2020
Q2 | $2K | Sell |
19
-293
| -94% | -$29.6K | ﹤0.01% | 2123 |
|
|
2020
Q1 | $31K | Hold |
312
| – | – | ﹤0.01% | 1071 |
|
|
2019
Q4 | $36K | Hold |
312
| – | – | ﹤0.01% | 1089 |
|
|
2019
Q3 | $39K | Hold |
312
| – | – | ﹤0.01% | 1008 |
|
|
2019
Q2 | $38K | Hold |
312
| – | – | ﹤0.01% | 984 |
|
|
2019
Q1 | $27K | Sell |
312
-7
| -2% | -$637 | ﹤0.01% | 1072 |
|
|
2018
Q4 | $32K | Hold |
319
| – | – | ﹤0.01% | 985 |
|
|
2018
Q3 | $37K | Hold |
319
| – | – | ﹤0.01% | 978 |
|
|
2018
Q2 | $29K | Buy |
319
+7
| +2% | +$591 | ﹤0.01% | 1047 |
|
|
2018
Q1 | $23K | Buy |
+312
| New | +$21.4K | ﹤0.01% | 993 |
|
Other funds holding HAE
AI
SignatureFD's HAE Position: Q2 2026 in Review
SignatureFD reduced its Haemonetics (HAE) stake by 70% in Q2 2026, selling an estimated $7.2K and leaving 49 shares worth $3.67K. The position accounts for ﹤0.01% of the portfolio, ranked #2967.
SignatureFD first reported a position in HAE in Q1 2018 and has held it in 34 quarters since. The position peaked at $40.2K in Q3 2023. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- SignatureFD held 49 shares of Haemonetics worth $3.67K as of Q2 2026.
- SignatureFD sold 112 Haemonetics shares in Q2 2026, an estimated $7.2K.
- Haemonetics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2967 holding.
- SignatureFD first reported a position in Haemonetics in Q1 2018 and has held it in 34 quarters since.
- SignatureFD's Haemonetics position peaked at $40.2K in Q3 2023.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.